Brief: Rhythm Biosciences Appoints David Atkins As CEO
24/04/2024 02:21
April 24 (Reuters) - Rhythm Biosciences Ltd RHY.AX :
* DAVID ATKINS APPOINTED CHIEF EXECUTIVE OFFICER
* OTTO BUTTULA, EXECUTIVE CHAIRMAN INTENDS TO STEP BACK TO
NON-EXECUTIVE POSITION
Further company coverage: RHY.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rhythm Biosciences
See all newsBrief: Rhythm Biosciences Says Gavin Fox-Smith Resigns As Chair
Brief: Rhythm Biosciences Announces Appointment Of Non-Executive Directors
Australia's Rhythm Biosciences rises on accelerating commercialisation of cancer test
Brief: Rhythm Biosciences Executes Distribution Agreement For Genetype
Brief: Rhythm Biosciences Seeks Trading Halt